Funder: Desmoid Tumor Research Foundation
Due Dates (Anticipated): May 2026 (Letter of Intent) | June 2026 (Full Application)
Funding Amounts: Up to $65,000/year (direct costs only), for 1–3 years per award. No indirect costs allowed.
Summary: Supports research on the mechanisms of spontaneous regression in desmoid tumors to advance understanding and inform new therapeutic strategies.
Key Information: Indirect costs are not permitted; cross-disciplinary collaborations are strongly encouraged.